Skip to content

Read-only version: For security reasons, the Research Information System (FIS) has been temporarily replaced by this read-only version. All public content and full texts remain available; login, editing, submission and statistics are not available. Questions: fis@uni-bamberg.de

Home › Publications › Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach) : multicentre, open-label, parallel, randomised controlled trial

Publication

Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach) : multicentre, open-label, parallel, randomised controlled trial

Hermanns, Norbert; Ehrmann, Dominic; Krichbaum, Michael; u. a. (2023): Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach) : multicentre, open-label, parallel, randomised controlled trial, in: The Lancet Regional Health - Europe, Amsterdam: Elsevier, Nr. Online, S. 1–12, doi: 10.1016/j.lanepe.2023.100702.

Details

Faculty/Chair
Faculty/Professorship
Author
Krichbaum, Michael
Haak, Thomas Jürgen
Freckmann, Guido
By
... ; Finke-Groene, Katharina; ...
Title of the Journal
The Lancet Regional Health - Europe
ISSN
2666-7762
Publisher Information
Elsevier : Amsterdam
Year of publication
2023
Issue
Online
Language
English
DOI
Abstract

Background

The majority of people with type 2 diabetes who require insulin therapy use only basal insulin in combination with other anti-diabetic agents. We tested whether using a smartphone application to titrate insulin could improve glycaemic control in people with type 2 diabetes who use basal insulin.

Methods

This was a 12-week, multicentre, open-label, parallel, randomised controlled trial conducted in 36 diabetes practices in Germany. Eligible participants had type 2 diabetes, a BMI ≥25.0 kg/m2, were on basal insulin therapy or were initiating basal insulin therapy, and had suboptimal glycaemic control (HbA1c >7.5%; 58.5 mmol/mol). Block randomisation with 1:1 allocation was performed centrally. Participants in the intervention group titrated their basal insulin dose using a smartphone application (My Dose Coach) for 12 weeks. Control group participants titrated their basal insulin dose according to a written titration chart. The primary outcome was the baseline-adjusted change in HbA1c at 12 weeks. The intention-to-treat analysis included all randomised participants.

Results

Between 13 July 2021 and 21 March 2022, 251 study participants were randomly assigned (control group: n = 123; intervention group: n = 128), and 236 completed the follow-up phase (control group: n = 119; intervention group: n = 117). Regarding the HbA1c a model-based adjusted between-group difference of −0.31% (95% CI: 0.01%–0.69%; p = 0.0388) in favour of the intervention group was observed. There were 30 adverse events reported: 16 in the control group, 14 in the intervention group. Of these, 15 adverse events were serious. No event was considered to be related to the investigational device.

Interpretation

Study results suggest that utilizing this digital health smartphone application for basal insulin titration may have resulted in a comparatively greater reduction in HbA1c levels among individuals with type 2 diabetes, as compared to basal insulin titration guided by a written titration schedule. No negative effect on safety outcomes was observed.

Funding

Sanofi-Aventis Deutschland GmbH.

GND Keywords
Diabetes mellitus Typ 2
Insulinstoffwechsel
App <Programm>
Smartphone
Keywords
Type 2 diabetes
Basal insulin
Insulin titration
Digital health tool
Titration app
DDC Classification
610 Medicine & health
RVK Classification
YC 6800
Peer Reviewed
yes
International Distribution
yes
Open Access Journal
yes
Type
Article
URI
Activation date
2023-08-11

Permalink: https://fis.uni-bamberg.de/handle/uniba/90005 · Data as JSON · Cite: BibTeX · RIS

Data as of: 2026-11-16

Restricted read-only access: login, editing and submission are temporarily disabled.